2020 American Transplant Congress » Poster Session A: Liver: Hepatocellular Carcinoma and Other Malignancies

3:30pm-4:00pm

Beyond Milan- Not Paying the Price

A. Mathur, C. Brennan, D. Tsapepas, M. Najjar, O. Perez, A. Griesemer, T. Kato, J. Emond

3:30pm-4:00pm

Center Effects on Post-Transplant Outcomes in Liver Transplantation for Hilar Cholangiocarcinoma

S. Nagai¹, T. Kitajima¹, G. Sapisochin², D. Moonka¹, T. Hibi³

3:30pm-4:00pm

Effect of 2015 T2 Hepatocellular Carcinoma Exception Policy Implementation on Waitlist Time and Tumor Characteristics

C. Durkin¹, D. E. Kaplan², T. Bittermann²

3:30pm-4:00pm

Efficacy of Radiofrequency Ablation in the Treatment of Patients with Hepatocellular Carcinoma and Compensated Liver Disease: A Pathological Evaluation of Liver Explants

W. Alhamoudi¹, I. Salih², S. Yousif², M. Shawkat³, K. Bzeizi², A. Albenmousa², S. Alghamdi², M. Sturdevant², D. Broering², H. Alsuhaibani²

3:30pm-4:00pm

HCC Liver Transplantation Waitlist Dropout Rates before and after the Mandated Six-Month Wait-Time

M. LaVere¹, K. Robichaux², J. Buggs³, E. Rogers³, S. Nyce⁴, A. Kumar¹, J. Sokolich³

3:30pm-4:00pm

Hepatocellular Carcinoma Recurrence after Severe Acute Cellular Rejection

M. Najjar¹, O. Perez¹, K. Bruestle¹, A. Qian¹, P. Jiang¹, A. Srivastava¹, Y. Saenger¹, E. Verna¹, E. Zheng¹, A. Mathur¹, A. Griesemer¹, K. Halazun², B. Samstein², T. Kato¹, J. Emond¹

3:30pm-4:00pm

Imaging Features and Diagnostic Accuracy of MRI in Combined Hepatocholangiocarcinoma

M. Najjar¹, J. Makkar¹, S. Sun¹, J. Zou¹, O. Perez¹, P. Jiang¹, Y. Saenger¹, E. Zheng¹, E. Verna¹, A. Mathur¹, A. Griesemer¹, K. Halazun², B. Samstein², T. Kato¹, J. Emond¹

3:30pm-4:00pm

Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond UCSF Criteria: Tumor Biology Not the Tumor Number Decide the Long Term Outcome- A Single Center Retrospective Analysis of Using Extended Criteria

A. Thorat, L. Jeng, S. Hsu, H. Yang, P. Li, T. Chen, K. Poon

3:30pm-4:00pm

Multimodal Strategy for Hepatocellular Carcinoma in the Elderly: To Transplant or Not to Transplant

M. Najjar¹, O. Perez¹, J. Zou¹, S. Sun¹, K. Bruestle¹, P. Jiang¹, E. Verna¹, E. Zheng¹, Y. Saenger¹, A. Mathur¹, A. Griesemer¹, B. Samstein², T. Kato¹, K. Halazun², J. Emond¹

3:30pm-4:00pm

Multiple Downstaging Episodes for Hepatocellular Carcinoma Prior to Liver Transplant Increases Risk of Post-Transplant HCC Recurrence

K. Mishra, M. Siddiqui, A. Farris, R. Salgia

3:30pm-4:00pm

Outcomes Following Deceased Donor Split/Partial Liver Transplant for Hepatocellular Carcinoma

L. Matsuoka, T. Sutcliffe, I. Feurer, S. Rega, S. Alexopoulos

3:30pm-4:00pm

Performance of the Retreat Score in Predicting Post-Transplant Hepatocellular Carcinoma Recurrence at a Large Academic Center

N. Mahmud, N. Philips, S. Ekpanyapong, S. Prenner, M. Levine, R. Reddy, M. Hoteit

3:30pm-4:00pm

Post-Transplant Recurrence Following Yttrium-90 Treatment in Liver Transplant Recipients with Hepatocellular Carcinoma

O. Rizzo, T. Kitajima, M. Kavousi, S. Yeddula, M. Rizzari, K. Collins, A. Yoshida, M. S. Abouljoud, S. Nagai

3:30pm-4:00pm

Standardized Incidence of De Novo Hematological Malignancies after Liver Transplantation – A Meta-Analysis of Global Transplant Registries

F. Ali¹, S. Soin¹, N. Saleem², P. Myint¹, M. R. Hussain³, B. Ali², A. Khan⁴, S. Nair⁵

3:30pm-4:00pm

The Prognostic Impacts of Recipient Gender in Deceased Donor Liver Transplantation for Hepatocellular Carcinoma

K. Sasaki, M. Sanghvi, M. Fujiki, T. Diago Uso, B. Eghtesad, C. Quintini, C. MIller, K. Hashimoto, C. D. Kwon, F. Aucejo

3:30pm-4:00pm

The Strategy and Utility of Checkpoint Inhibitor Therapy in Patient with Hepatocellular Carcinoma Recurrence Following Liver Transplantation

L. Jeng, S. Hsu, A. Thorat

3:30pm-4:00pm

Waiting List Mortality of Liver Tumors

V. G. Menon, Y. Chen, D. C. Chang, H. Yeh